* Awarded up to $132 million to develop portfolio of new
antibiotics targeting drug-resistant infections under strategic
partnership with BARDA
The post BRIEF-Medicines Co receives funding of up to $132 mln from BARDA appeared first on NASDAQ.
BRIEF-Medicines Co receives funding of up to $132 mln from BARDA
